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ABSTRACT
Biaryl bonds are a common motif found in biologically active compounds and
the majority of marketed pharmaceuticals. The contemporary methods used to
synthesize these biaryl bonds, albeit high yielding, are not economical because they
require several prefunctionalization steps that create a high volume of waste and
byproducts. Cross-dehydrogenative coupling (CDC) is the future of green coupling
techniques, since it requires no prefunctionalization of substrates and can obtain high
yields with a relatively low catalyst loading. Herein, we report on advances being
made in the field of CDC, and our own efforts to achieve cross coupling utilizing
benzimidazole moieties.
The first manuscript, “Aryl-Aryl Bond Formation via CDC Reactions” is a
comprehensive review of the latest and most notable achievements being made in the
area of biaryl CDC reactions. The manuscript focuses on cross-dehydrogenative
coupling as a green method that can be used to create aryl-aryl bonds on a vast array
of substrates. Several different classes of CDC reaction conditions were examined
including Pd, Rh, Ru, Cu, and Fe-based catalytic systems.
The second manuscript, “Intramolecular Arylation of Benzimidazoles via
Pd(II)/Cu(I) catalyzed Cross-Dehydrogenative Coupling” describes research done on
the intramolecular biaryl CDC reaction between simple arenes and benzimidazoles.
This novel reaction is carried out on N-benzylbenzimidazoles that upon cyclization
forms a fused polycyclic system. The reaction conditions were optimized and tested on
a large library of substrates, and the mechanism was probed using kinetic isotope
studies and varied reaction conditions to suggest a unique Pd(II)/Cu(I) catalytic cycle.
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PREFACE
The following work is presented in manuscript format according to the
guidelines presented by the University of Rhode Island Graduate School. The thesis
will consist of two manuscripts that are currently in the process of publication.
Manuscript 1 entitled, “Aryl-Aryl Coupling via CDC Reactions” is being
published in 2014 as a chapter in the book “Carbon-carbon Bond Formations via
Cross-Dehydrogenative Coupling of C-H Bonds” by the Royal Society of Chemistry
and edited by C. J. Li.
Manuscript 2 entitled, “Intramolecular Arylation of Benzimidazoles via
Pd(II)/Cu(I) catalyzed Cross-Dehydrogenative Coupling” has been presented as a
poster at the 252nd ACS National Meeting and Exposition in Philadelphia (August
2012) and will be submitted to Tetrahedron Letters for publication in October 2013.
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INTRODUCTION

The formation of aryl-aryl bonds is one of the most fundamental reactions in
organic synthesis. Biaryls are contained in many bioactive therapeutic agents
including, anti-inflammatory, antifungal, antiviral, and anticancer agents,1 making it a
highly desirable motif to the pharmaceutical industry.2 Also, many useful synthetic
materials contain biaryls, including dyes, semiconductors, agrochemicals, and many
types of ligands.3 With such a vast scope of uses, the ability to easily synthesize these
aryl-aryl functionalities on nearly any compound is a demand that researchers have
been trying to improve on over the past century.
One of first published examples of aryl-aryl bond formation was the Ullmann
reaction originally published in 1901.4 The Ullmann reaction was able to synthesize
symmetric biaryls by heating two equivalents of an aryl-halide and one equivalent of
copper at very high temperatures. This reaction was a great success; however, it
utilized a stoichiometric amount of copper metal and had limited success with nonsymmetric coupling. Despite these shortcomings, aryl-aryl bonds continued to be
made mainly using copper Ullmann type conditions until the 1970s.3
Only in the past few decades has the use of other transition metals like Pd, Pt,
Rh, and Ru taken a prominent role in aryl-aryl bond formation. These metals can be
used in catalytic amounts and can catalyze cross coupling as well as homocoupling of
arenes. The use of Pd especially has become common since the Kumada cross
coupling conditions on olefins were shown to work with a Pd catalyst in 1975 by
Murahashi.5 Palladium has since been found to work very well in aryl-aryl bond
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formation because of its ability to tolerate a wide variety of organometallic
nucleophiles including tin, silica, boron, lead, and magnesium species.3 Today, most
of the contemporary biaryl coupling techniques utilize catalytic amounts of Pd to form
aryl-aryl bonds. Some of the more common ones are highlighted in (Scheme 1).

Scheme 1- Conventional Biaryl Coupling Techniques

All of the Pd catalyzed aryl coupling techniques above are theorized to operate
under a similar mechanistic scheme. (Scheme 2) There are three main steps to the
catalytic cycle, the first of which is oxidative addition of the Pd(0) catalyst into the Chalogen bond of an aryl-halide. As the Pd is inserting it forms two new covalent bonds
and is oxidized to a Pd(II) complex with one aryl group and a halide. This oxidative
addition step is often the rate-limiting step of the catalytic cycle.6 Next,
2

transmetalation occurs, and a second aryl group is swapped for the halide on the Pd(II)
complex from another aryl-metal species, such as B, Sn, or Zn. This step loads both
aryl groups on the Pd without changing the oxidation state of either metal during
transmetalation.

Scheme 2- Catalytic Mechanism for Conventional Coupling Techniques

The final step is reductive elimination of the two aryl groups from the Pd(II)
complex, which simultaneously forms a new biaryl bond and reduces Pd back to its
original state. The Pd is then poised to undergo the cycle again.
Although most of these coupling methods are extremely robust, they still have
short-comings. All of these methods have one main problem: the aryl groups must be
prefunctionalized with halogens and metals. This is costly in terms of the time
required to make the prefunctionalized aryl-metals and aryl-halides, and in terms of
the waste generated from the additional reactions and purification steps.7 Therefore,
“greener” methods to synthesize these biaryl bonds are being sought.
3

A method that would cut out costly prefunctionalization steps and couple
simple hydrocarbons, would be ideal. Therefore, much research has lately been
focused on cross-dehydrogenative coupling (CDC) as a means to synthesize biaryls.
CDC is desirable due to the fact that two simple C-H bonds can be coupled, throwing
out the need to prefunctionalize and giving a higher overall step economy.
Mechanistically, palladium-catalyzed CDC differs from traditional coupling
techniques because it undergoes a Pd(II)/Pd(0) catalytic cycle instead of a Pd(0)/Pd(II)
catalytic cycle. Because Pd(0) is not able to oxidatively insert into a C-H bond, a
Pd(II) source is used to facilitate two separate C-H activations through means such as
concerted metalation deprotonation or electrophilic aromatic metalation.8-9 (Scheme 3)
Once the aryl groups are loaded onto the Pd, reductive elimination then occurs
generating the product and leaving Pd in its reduced state. The final step is to oxidize
Pd(0) back up to Pd(II) for the cycle to start again.

Scheme 3- Catalytic Mechanism for CDC

4

When comparing traditional coupling techniques to CDC, it is clear that CDC
is the greener method. For economical and environmental reasons, it appears that the
future of biaryl coupling should be in CDC. Much research is now being devoted to
developing new aryl-aryl CDC reactions and making them as green as possible by
eliminating superfluous reagents from the reaction. The research described herein will
provide an in depth look into cross-dehydrogenative coupling, by examining its
advantages and shortcomings, and how it can be utilized in the formation of aryl-aryl
bonds.

5
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MANUSCRIPT 1

Aryl-Aryl Bond Formation via CDC Reactions

Abstract
The formation of biaryl motifs via oxidative coupling of hydrocarbons is a
challenging and highly sought after process in both academia and industry.
Contemporary biaryl coupling techniques include prefunctionalization steps that lower
the overall step economy of the reaction and increase expenses and waste. The cross
coupling of C-H bonds is a green technique that requires no prefunctionalization and
can significantly lower wasteful byproducts. This chapter highlights advances in the
field of oxidative coupling of hydrocarbons through biaryl cross-dehydrogenative
coupling (CDC). It includes insight into a variety of CDC methods including aerobic
coupling and metal catalyzed CDC using metals such as: Pd, Rh, Ru, and Cu.
General Introduction
Currently there is a need for environmentally friendly ways to incorporate
carbon-carbon bonds into organic molecules. Specifically, biaryl C-C bonds are of
high priority, since aryl or heterocyclic groups are contained in 75% of marketed
pharmaceuticals.1 The traditional methods for making biaryl C-C bonds include
Suzuki, Negeshi, Stille, and Kumada coupling,2 all of which involve the coupling of
an aryl-halide and an aryl-metal species. These methods might appear green since they
use small quantities of metal catalysts and require no external oxidant. However, they
suffer from wasteful and costly prefunctionalization steps and poor atom economy.3
8

The ideal scenario would be to oxidatively couple two aryl C-H bonds and
produce a new biaryl C-C bond. This coupling method, herein known as crossdehydrogenative coupling (CDC), would require no prefunctionalization steps and
generate fewer byproducts as waste (Scheme 1).

Scheme 1- Biaryl Synthesis via CDC and Traditional Suzuki Coupling Techniques

Compared to traditional coupling techniques, CDC would provide a greener
synthetic route by improving the overall step economy of the reaction, since
functionalization is not a prerequisite in CDC. The number of additional steps required
to install functional groups prior to coupling is often time consuming, expensive, and
wasteful.
In 1912, the first oxidative biaryl coupling was reported by Scholl, in which
simple arenes were coupled using a stoichiometric amount of AlCl3.4-5 Since the
introduction of the Scholl reaction, publications of biaryl CDC reactions have
continued to grow, attracting much interest in both academic and industrial settings.
However, these reactions come with many challenges that must be overcome before
they can be implemented in industry.

9

One of the main challenges with CDC methodology is finding ways to readily
activate C-H bonds, since they are short, strong, and hard to activate via oxidative
addition with organometallic complexes. Traditional coupling methods, such as the
Suzuki reaction, are successful because prefunctionalization with a halogen or boronic
acid creates species that are amenable to metalation via oxidative addition or
transmetallation. Another challenge is using inexpensive and readily available
oxidants. Coupling between two C-H bonds could ideally produce hydrogen gas as a
byproduct; however, that is often thermodynamically unfavorable; thus, requiring an
external oxidant to drive the reaction forward.6 Finally, controlling the selectively of
C-H activation has proved difficult. Unwanted dimer byproducts often plague CDC
reactions, and finding conditions that minimize homocoupling is difficult.
Regioselectivity is the other selectivity problem due to the omnipresence of C-H
bonds. Many times this is resolved by the use of a preinstalled directing group that can
coordinate with a metal catalyst to facilitate insertion into a nearby C-H bond.
Despite the difficulty of biaryl synthesis via CDC, much progress has been
made on the subject over the past century, with most of the advances being realized in
the past decade. This chapter will focus on some of the exciting highlights and recent
advancements of these green reactions.
Pd Catalyzed CDC Systems
Although many different metal catalysts have been used in oxidative coupling
reactions, the most common ones are late transition metals, including Pd, Rh, Ru, and
Cu.2 Undoubtedly, Pd is used in the majority of examples, probably due to its high
versatility and activity.7 The first biaryl dehydrogenative coupling reaction catalyzed
10

by Pd was reported by Van Heldon and Verberg, in which biphenyl was formed in
high yields.8 This initiated a wave of studies using Pd catalysts in CDC reactions.
Because Pd(0) has the potential to easily form a colloid and fall out of solution, a
ligand or solvent system that can coordinate Pd(0) can be used to ameliorate this
problem.9 However, the phosphine ligands that are commonly employed in traditional
cross coupling chemistry are not stable in the oxidizing environments required for
most CDC reactions, so simple palladium salts are often used, such as Pd(OAc)2 or
PdCl2.7 Hartwig and co-workers observed that ligandless anionic palladium species
more readily cleave C-H bonds compared to hindered phosphine ligated palladium
catalysts.10 Thus providing evidence as to why most Pd catalyzed CDC reactions work
efficiently without ligands. Pd catalyzed CDC reactions typically run in an acidic
medium for up to several days11 at a temperature over 100 °C. An external oxidant is
needed in these reactions. The greenest option is to use O2; though, other less green
alternatives including peroxysulfates and metal salts of Cu(II) or Ag(I) are more
common.
Molecular Oxygen as an Oxidant and Ligand Controlled Regioselectivity.
Several groups have successfully utilized molecular oxygen as the sole oxidant in
aerobic Pd catalyzed biaryl CDC reactions. These reactions are probably the greenest
CDC reactions that exist right now due to the fact that using O2 or air as the oxidant is
inexpensive and makes water as a final biproduct. Most of these O2 oxidized reactions
take place in an acidic environment and at temperatures ranging anywhere from 55120 oC.
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In 1973, Yoshimoto and Itatani successfully carried out a biaryl Pd catalyzed
dehydrogenative coupling reaction with pressurized O2 as the oxidant.12 They coupled
biphenylethers intramolecularly, but also got an equal amount of intermolecular
dimers as side products. The experimental conditions were harsh (50kg/cm2 of 1:1
oxygen and nitrogen and heated to 150 °C) and were not regioselective. In 1999,
Akermark and co-workers published a Pd catalyzed CDC reaction that
intramolecularly coupled arylaminoquinones.13 This reaction worked in only 1 atm. of
O2; however, when coupling biphenylethers or biphenylamines, the reaction required
additional tin(II) acetate additives to prevent bulk Pd from falling out of solution.
Later, the groups of Fagnou, Ohno, and Kandekar developed improved
intramolecular aerobic CDC examples in which all experimental conditions included a
Pd(OAc)2 catalyst, a base, pivalic or acetic acid, and oxygen (Scheme 2). These
reactions were successful on biphenylethers14 and biphenylamines14-15 up to 99% yield
and N-benzoylindoles14,16 and N-benzoylpyrroles17 up to 92% yield.

Scheme 2- Pd-catalyzed Aerobic Intramolecular CDC reactions
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Several examples of aerobic intermolecular coupling via CDC of aryls were
also published, using similar conditions.18-19 Perhaps the most interesting example to
date was by Stahl and co-workers in 2011. They aerobically coupled indoles and
arenes via intermolecular CDC using Pd catalysts and diazafluorene ligands.20 While
optimizing the reaction, they found that both the anionic ligands in the Pd(II) salts and
the neutral diazafluorene ligands could control regioselectivity (Scheme 3).

Scheme 3- Arylation of Indoles via CDC with Ligand Controlled Regioselectivity

The combination of the pivalate anion with a diazafluorenone ligand was
selective for C2 coupling, whereas the combination of the trifluoroacetate anion with a
dimethyldiazafluorene ligand was selective for C3 coupling. In both catalyst systems
the presence of electron donating groups deteriorated the regioselectivity; however the
presence of electron withdrawing groups improved selectivity with the C2 selective
catalyst system.
Oxidant Controlled Regioselectivity. Another aspect that has been shown to
readily influence site selectivity in CDC reactions is the choice of oxidant (Scheme 4).
13

Scheme 4- Scope of Oxidant Controlled Regioselectivity

In 2007, DeBoef and co-workers showed that regioselectivity could be
manipulated in the arylation of benzofurans with different oxidants.21-22 They found
upon examining the reaction in acidic conditions, that CDC reactions employing the
heteropoly acid H4PMo11VO40 (HPMV) gave almost exclusive C2 site selectivity. The
use of Cu(OAc)2 also gave moderate C2 selectivity, and the use of AgOAc gave no
selectivity. That same year Fagnou and co-workers showed that, when arylating
indoles, regioselectivity could be controlled by using different oxidants.23-24 They
found that using Cu(OAc)2 gave C3 selectivity and using AgOAc gave C2 selectivity.
Further studies have come from the DeBoef group on oxidant controlled
regioselectivity, in which both benzofuran and indole arylations were examined in
different solvent parameters.25-27 They summarized that solvent had little overall effect
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on regioselectivity compared to oxidant choice,27 and both DeBoef and Fagnou
reasoned that site selectivity is most likely due to the formation of polymetallic
clusters during catalysis.23-24,25
Catalytic Oxidants with O2 Terminal Oxidant. Using O2 as the only oxidant
is, to date, the greenest condition for the synthesis of biaryls via CDC; however,
several studies have shown that catalytic amounts of a metal oxidant can be used along
with O2 as a terminal oxidant (Scheme 5).12,22,28-30

Scheme 5- Redox Cycle for a Pd catalyzed CDC with a catalytic metal oxidant
and O2 terminal oxidant

These “cocatalyst” oxidants are sometimes needed to help prevent bulk Pd
from falling out of solution, they are often strong oxidants that can readily reoxidize
Pd(0) back to Pd(II) before it falls out of solution.13 Transition metal salts, such as
Sn(OAc)2,13, Ag2O,29 Cu(OTf)230 and Mn(OAc)3·H2O,31 have been used, but perhaps
one of the most unique examples was by DeBoef and co-workers in which they used
the heteropoly acid HPMV as a cocatalyst oxidant to afford high yields in the arylation
of benzofurans via CDC reactions (Scheme 6). 22
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Scheme 6- Aerobic arylation of benzofuran via Pd catalyzed CDC and catalytic HPMV oxidant

Heteropoly acids have been shown to be quite efficient as catalytic oxidants
due to their highly reversible oxidizability.31 The study utilized these efficient
oxidants, and found that they contributed to high yields, and would tolerate substrates
containing the presence of electron donating groups on the aryl moiety, which
increased the reaction rate. Alternatively, the presence of electron withdrawing groups
shut down the reaction.

Subsequent mechanistic studies have shown that the

HPMV/O2-oxidized reactions proceed via a Pd(II)/Pd(IV) mechanism.27
Organic Peroxide and F+ Oxidants. Another green oxidant option for Pd
catalyzed biaryl CDC reactions is to use organic peroxides or F+ oxidants such as
sodium persulfate (Na2S2O8) or N-fluorobenzenesulfonamide (NFSI) (Scheme 7).

16

Scheme 7- Pd Catalyzed CDC reactions utilizing organic peroxide and F+ oxidants

All of these are strong oxidants and are simultaneously inexpensive and
environmentally friendly, since they do not contain transition metals.32 Given that
these peroxides and F+ reagents are even stronger oxidants than most metal salts, it has
been proposed that they are capable of causing the CDC to go through a Pd(II)/Pd(IV)
catalytic cycle rather than the usual Pd(0)/Pd(II).34-36 A directing group is used in
most of the Pd catalyzed biaryl CDC reactions with organic oxidants, most likely to
help control site selectivity.
The oxidant, sodium persulfate, has been used in several Pd catalyzed biaryl
CDC reactions by such groups as Dong, Cheng, Lu, and Knochel, all of which also
used a strong acid, such as TFA.32-34,37-39 Strong acids are proposed to aid metallation
of the C-H bond by increasing the electrophillicity of the Pd catalyst.32 These biaryl
CDC reactions oxidized by sodium or potassium persulfate couple simple arenes
(several with directing groups), and can even be used to make phenanthridinone
derivatives (e.g. 1, Scheme 7).33 The Dong group has also shown that using sodium
persulfate is an effective oxidant in the CDC of arenes with O-pheynylcarbamates.32
17

Their coupling reaction achieved up to 98% yield and worked on a large library of
substrates (e.g. 2, Scheme 7). Finally, exciting new work has come out of the labs of
Yu and Seayad that utilize F+ oxidants.35-36 These F+ oxidants were used along with Pd
catalysts and ligand sources to couple simple arenes35 or arylate furans36 in yields up
to 85% (e.g. 3, Scheme 7).
Stoichiometric Metal Oxidants. The most widely used conditions for biaryl
CDC reactions require stoichiometric amounts of metal oxidants. Although
stoichiometric metal oxidants make them the least green of all the Pd catalyzed CDC
reactions, they are still attractive due to the fact that the starting materials do not need
prefunctionalization. The most frequently used metal oxidants are Ag(I) and Cu(II)
salts. Both have been shown to work readily in the inter- and intramolecular coupling
of simple arenes and heterocycles, and as seen in the section Molecular Oxygen as an
Oxidant and Ligand Controlled Regioselectivity, DeBoef and Fagnou have even
shown that metal oxidants influence regioselectivity.21-27
Silver (I) salts have been used extensively as oxidants in many different types
of biaryl CDC reactions, such as the arylation of indoles,23-24,40-42 azoles,43
thiophenes,44 chromones,45-46 xanthines,47 uracils,48 and pyridine N-oxides.41-42,49 They
are also used in inter- and intramolecular coupling of simple arenes.50-55 Recently,
Zhang and co-workers oxidatively coupled thiophene derivatives and fluorinated
arenes, using only 2.5 mol percent of Pd(OAc)2 as a catalyst and AgCO3 as an oxidant
(Scheme 8).44
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Scheme 8- Pd Catalyzed CDC of Thiophenes and Fluorinated Arenes with a Ag(I) Oxidant

Their reaction worked on a large library of thiophene substrates, and was even
shown to arylate benzofurans and indoles in the same conditions. The reaction also
tolerated a vast array of functionalities including, amides, esters, aldehydes, and
olefins. These perfluoroarene-thiophene compounds are being used in various
electronic materials including diodes and transistors,44 making Zhang’s reaction a
superior way to produce these materials.
Another interesting Pd catalyzed CDC reaction with a Ag oxidant was reported
by the Sanford group in which they intermolecularly coupled arenes in high yields and
high regioselectivity (Scheme 9).55

Scheme 9- Pd catalyzed CDC of benzoquinoline and arenes with a Ag(I) oxidant
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Intermolecular coupling between two arenes is less common due to the fact
that heterocycles are easier to regioselectively functionalize due to the intrinsic
electronic differences of the C-H bonds.55 The Sanford group solved this problem by
using benzoquinoline as one of their coupling partners. The substrate’s basic nitrogen
served as a directing group that coordinated Pd and, thus, controlled site selectivity.
They were able to achieve moderate to high yields, even in the presence of electron
withdrawing and electron donating functionalities on the arenes.
Copper(II) salts are commonly used oxidants. They are relatively inexpensive,
and have been shown to work in a wide array of Pd catalyzed CDC reactions such as
the arylation of heterocycles,22-25,27,56-57 and intermolecular coupling of arenes.58
However in biaryl synthesis, they are chiefly utilized in intramolecular couplings22,59-64
and the cross coupling of heterocycles.64-67
In 2011, Greaney and co-workers used a Cu(OAc)2 oxidant with a Pd(OAc)2
catalyst for an intramolecular CDC reaction that created medium-sized, biarylcontaining rings (Scheme 10).62

Scheme 10- Medium ring synthesis via intramolecular Pd catalyzed CDC with a Cu(II) oxidant
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This reaction was unique in that it formed seven- and eight-membered rings,
instead of the usual aromatic five member rings, as in the formation of
carbozoles.15,30,51,60 Medium-size rings occur naturally in many biologically active
compounds, and are generally more difficult to synthesize than small rings and large
macrocycles, making methods for their synthesis highly desirable.62 Greaney’s group
was able to achieve the synthesis of these rings and incorporate indole into their
products, since indole is a common biologically active moiety. The reaction gave high
yields, and worked with several other heterocycle coupling partners, like azoles. It also
had an exceptional tolerance for amine and ether functionalities within the newly
formed rings.
Another interesting Pd mediated reaction with a Cu(II) oxidant comes from a
study by the You group in 2011, in which they were able to cross couple heterocycles
in high yields with good regioselectivity (Scheme 11).67

Scheme 11- Pd catalyzed cross coupling of heterocycles with a Cu(II) oxidant

You used a [Pd(dppf)Cl2] catalyst and a Cu(OAc)2·H2O oxidant system. They
also added a catalytic amount of X-Phos ligand, to prevent decomposition of indole
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derivatives, and a CuCl additive, that further helped control regioselectivity. The
reaction conditions were found to couple a wide array of heterocycles including,
xanthines, pyridine N-oxides, azoles, indoles, and pyrroles in good to excellent yields.

Rhodium and Ruthenium Catalyzed CDC Systems
Catalysts based on rhodium and ruthenium are becoming increasingly popular
for the synthesis of biaryls via CDC reactions. Palladium catalysts, although they
exhibit good functional group tolerance and require mild reaction conditions, often
need 10-20 mol % catalyst loading and a gross excess of one of the coupling substrates
for a reaction to reach completion.68 Rhodium and ruthenium, on the other hand, have
many of the same catalytic properties as Pd,68 but usually require less catalyst loading
(1-5 mol %) and have potentially novel selectivity properties.69 Newfound interest in
these metals as catalysts for biaryl CDC has been growing since a study on Ru
catalyzed dehydrogenative coupling of 4-pyridines by Suzuki and co-workers in
2007.70
Rhodium catalyzed oxidative biaryl coupling is still in its infancy, given that it
first started appearing in independent studies by Glorius, Miura, and You in 2012. All
of these studies used either Rh(I) or Rh(III) catalysts and Cu(II) oxidants to carry out
arylations of heterocycles,68 intramolecular couplings71 or dual heterocycle
couplings.69,72
One example by Glorius and co-workers showed that a Rh(III) catalyst in the
presence of a AgSbF6 cocatalyst, could successfully couple two arenes with the use of
a tertiary benzamide directing group (Scheme 12).68
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Scheme 12- Rh catalyzed biaryl CDC with a tertiary benzamide directing group

It was suggested that the AgSbF6 was involved in generating an electrophillic
Rh(III) species as the active catalyst. This reaction was remarkable in that it took only
5 mol% catalyst loading and achieved high yields and regioselectivity. Both electron
withdrawing and electron donating groups were tried in different positions on the
arenes resulting in moderate to high yields with close to a 3:1 meta/para
regioselectivity in most cases. It is also interesting to note that the reaction did not
couple to the ortho position of bromobenzene; making it possible to exclusively
synthesize meta-substituted biaryls using 1,3-haloarenes.
Ruthenium has been used in several oxidative homocoupling reactions;70,73-74
however, its use in oxidative cross coupling is brand new. The You group recently
published the initial findings of a novel Ru catalyzed biaryl CDC, wherein 2methylthiophene was successfully coupled to both benzoquinoline and quinoxaline
motifs (Scheme 13).72
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Scheme 13- Ru catalyzed CDC of methylthiophenes with benzoquinolines and quinoxalines

This reaction, although not extensively studied yet, exhibited moderate yields with
high regioselectivity.

Copper Mediated CDC Systems
Palladium is used in the majority of biaryl CDC reactions; however copper
would be an ideal economical alternative since it is abundant and relatively
inexpensive.75 It has seen historical use in oxidative naphthyl homo-couplings to
synthesize chiral ligands like BINOL.76-78 Although, due to the radical nature of the
reaction, the hetero-coupling of naphthyls has proved to be a difficult task since
radical-radical recombination produces a majority of homo-coupled products.79
Several groups have found solutions to this,79-83 including Collins and co-workers,
who used NHC (N-heterocyclic carbene) ligands in a bis-NHC-Cu(II) complex to
catalyze the cross coupling of naphthyl derivatives via CDC (Scheme 14).79
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Scheme 14- CDC of naphthyl derivatives by a N-heterocyclic carbene-Cu(II) complex

The presence of the NHCs greatly effects the electronic properties of the Cu(II)
making it possible to cross couple naphthyls. The CDC was believed to proceed via a
radical-addition mechanism.
All other Cu mediated CDC reactions fall under two groups: Daugulis
iodination conditions,84-85 and Miura’s CDC arylation of heterocycles.75 Daugulis’s
conditions include the presence of a Cu(I) salt and I2 (Scheme 15).85

Scheme 15- Daugulis conditions for iodination and direct arylation using CuI/I2

It is known to proceed through a one-pot iodination and then Cu mediated
direct arylation. The fact that the reaction is prefunctionalizing one of the C-H bonds
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perhaps makes it not a true CDC; however, the reaction requires no initial
functionalization steps beforehand giving it the outward appearance of a CDC.
Daugulis and co-workers have used their CuI/I2 conditions on the coupling of a vast
array of heterocycles as well as both electron rich and electron poor substrates, making
this a highly versatile reaction.
The final category of Cu mediated biaryl CDC is the work by Miura and coworkers in 2011. Miura was able to cross couple arenes with a variety of azoles using
excess Cu(OAc)2 (Scheme 16).75

Scheme 16- Cu catalyzed CDC of pyridyl arenes and azoles

The reaction gave moderate yields, and the use of a directing group on the
arenes provided high regioselectivity. Even though this reaction used excess
Cu(OAc)2, it is still desirable because copper is more economical than other catalytic
metals like Pd. Daugulis86 and Mori87 have successfully shown that catalytic Cu can
be used in aryl oxidative dimerizations. Therefore, the goal of using Cu in catalytic
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amounts for biaryl CDC, aside from radical naphthyl or iodination coupling, seems
promising.

Other CDC Systems
To date there are only a few other examples of CDC systems used for biaryl
coupling. The majority of them fall under single electron transfer (SET) oxidants like
hypervalent iodine reagents. Kita and co-workers have monopolized the field of using
hypervalent iodine in biaryl CDC reactions.88-92
Hypervalent iodine oxidants are known to be safe,88 mild oxidants89 that can
readily form aromatic cation radicals with electron rich arenes through SET.90 They
usually require low temperatures and short reaction times. Unwanted dimerization can
often plague these aryl CDC reactions, so Kita typically uses one coupling partner like
naphthalene, which is electron rich and prone to forming an aromatic cation radical
with a hypervalent iodine oxidant, and a second coupling partner that is more
nucleophillic so as to cause a nucleophillic attack on the radical and subsequent cross
coupling.90 Kita and co-workers have also shown that using hypervalent iodine
reagents to couple thiophenes can form intermediate thienyl iodonium(III) salts
(Scheme 17).89 The formation of these intermediate salts effectively eliminates
dimerization and gives excellent regioselectivity. The reaction tolerated a large library
of functionized arenes and heterocycles and gave moderate to high yields.
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Scheme 17- Hypervalent iodine mediated CDC of thiophenes with arenes and heterocycles

A few remaining CDC systems include V(V) catalytic systems,93 and Tl(III)
catalytic systems;94-95 both of which have been used in intramolecular aryl coupling
via free radicals, although in low yields and harsh reaction conditions. Autoxidizing
CDC conditions developed by Bergman are also of interest, in which one of the
coupling partners, quinoline, serves as the sole oxidant as it is coupled to indole or
pyrrole moieties.96 Finally, the use of iron in biaryl CDCs is also being developed.97-99
Katsuki and co-workers published a study in 2011 on an aerobic Fe catalyzed cross
coupling of naphthol derivatives to make unique BINOL ligands (Scheme 18).97
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Scheme 18- Aerobic Fe catalyzed CDC of naphthols

This reaction was quite green since it used an iron catalyst, which is non-toxic
and inexpensive, and only a 4 mol % catalyst loading. Also, the oxidant was molecular
oxygen from the air, giving off water as a biproduct. The reaction was suggested to go
through a radical-addition, and produced moderate yields and high enantioselectivity
on a wide range of substrates. This makes it a desirable new method for synthesizing
enantiomeric BINOL ligands.
Future efforts in the CDC of arenes will perhaps include enzyme mediated
reactions, since enzymes have low toxicity, high catalytic turnovers, and are able to
run in very mild conditions. In 2006,100 d’Ischia and co-workers used peroxidase
enzymes to catalyze the oxidative dimerization of indole derivatives. This technology,
albeit low yielding, appears to be an excellent lead to optimize for crossdehydrogenative coupling.
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Intramolecular Arylation of Benzimidazoles via Pd(II)/Cu(I) catalyzed CrossDehydrogenative Coupling

Abstract
Electron poor benzimidazole substrates were arylated via an intramolecular
cross-dehydrogenative coupling (CDC) reaction. These CDC reactions were catalyzed
by a Pd(II)/Cu(I) catalyst system, capable of producing moderate yields on a large
library of substrates. The substrate scope consisted of tethered arene-benzimidazoles
that upon coupling, produced a fused polycyclic motif.

Introduction
The biaryl motif is a prominent structure in many biologically active
compounds, and green methods to synthesize these biaryl bonds are highly desired.1
Conventional aryl coupling methods (i.e. Suzuki2 or Stille3 coupling) contain
prefunctionalization steps to form activated C-metal or C-halogen bonds, which can
readily undergo catalytic coupling. However, this prefunctionalization decreases the
overall step economy of the synthesis and produces large amounts of waste. A far
more advantageous coupling method would be cross-dehydrogenative coupling
(CDC). It can be used to inter- and intramolecularly couple two aryl hydrocarbon
bonds, requiring no prefunctionalization of substrates and affording high yields with
minimal byproducts and waste (Scheme 1).
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Scheme 1- The Conventional Suzuki-Miyaura Cross Coupling Method vs. CDC

Much attention has been given to incorporating heterocycles into biaryl CDC
reactions, since heterocyclic components are often found in nature and a play a
prominent role in pharmaceutical candidates.1 The benzimidazole moiety alone has
been shown to have many important uses including an antiviral for HIV-1,4
antibacterials,5-6 and possible anticancer agents.7 However, imidazoles are rarely
found as a coupling substrates in CDC reactions. Mori and coworkers have shown an
efficient homocoupling reaction for imidazoles,8 and the You group has found success
coupling imidazoles to electron rich substrates like thiofurans.9-10 However, oxidative
coupling between imidazoles and benzenes has proved to be a challenging task.
Dominguez and Dubois have arylated imidazoles using aryl iodides,11-12 but, to our
knowledge, the only example of coupling imidazoles with simple arenes via CDC is
the coupling of N-styryl-imidazoles by Bao and coworkers.13
With this in mind, we decided to try palladium catalyzed CDC reactions
between benzimidazoles and arenes. To help overcome coupling difficulties, the arene
was tethered to the benzimidazole prior to coupling by installing an N-benzyl
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substituent. The tether would help in the metallation of both coupling partners by
keeping them in close proximity to each other, and at the same time reducing
unwanted dimerization. CDC should cause this tethered substrate to cyclize into a
fused polycyclic system.

Results and Discussion
The optimization studies for this reaction were performed on N-benzyl
benzimidazole, substrate 1, which was synthesized through a substitution reaction
using deprotonated benzimidazole and benzyl chloride. Substrate 1 was then purified
by column chromatography and afforded a 70% yield. Initially, we thought that a
Cu(I) halide source would be a beneficial catalyst since it has been shown that CuI
can arylate the C2 position on azoles via intramolecular coupling with aryl iodides.11
Since 1 did not contain a halogen, it was also theorized that a catalyst such as
Pd(OAc)2 would be needed to activate the aryl C-H bond. However both
Pd(OAc)2/CuI and Pd(OAc)2/CuCl catalyst systems proved to be ineffective, since
they both gave low conversion of starting materials and a mixture of byproducts. Next,
a rhodium based catalyst, [RhCl(coe)2]2, was tried, but it suffered from low yields and
dimerization. Simply using Pd(OAc)2 as the catalyst with a Cu(OAc)2·H2O oxidant
provided a superior system, therefore further optimization reactions were run with this
catalyst system (Table 1).
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Table 1- Optimization of the Reaction Conditions

At the outset, undesired byproducts including the dimer 4 and the acetoxylated
compound 3 plagued the reaction. It was found that lowering the amount of
Cu(OAc)2·H2O oxidant helped reduce the amount of acetoxylated products since the
amount of acetate anion was reduced. Also simply lowering the temperature and time
of the reaction helped lower byproduct formation. Interestingly, the addition of
CsOPiv (Table 1, entry 5) eliminated compound 3, most likely due to the steric nature
of the pivalate anion. It has been suggested by Fagnou that the addition of pivalate
helps facilitate C-H bond cleavage by forming Pd(OPiv)2 prior to palladation.14-16
Fagnou and coworkers also showed that reactions performed in pivalic acid instead of
acetic acid greatly reduced unwanted oxidative byproducts including dimers.14
Upon doubling the amount of Pd(OAc)2, compound 2 was recovered in a
nearly twofold yield (Table 1, entry 6), suggesting that catalyst turnover was a
problem in the reaction. After many trials, the optimal time and temperature for the
coupling reaction was found to be 3 hours at 150 ºC under microwave heating (Table
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1, entry 8). The longer reaction times led to a decrease in product, perhaps due to
decomposition (Table 1, entry 9). Finally, we were excited to discover that the
addition of 0.5 equivalents of CuOAc, improved the yield, giving the best isolated
yield of 58% (Table 1, entry 10).
Another interesting observation during the optimization of this reaction was
the copper coloration present in the organic layer while extracting the product. Cu(II)
has been known to coordinate to pyrazole ligands in isolatable complexes;17 thus we
speculated that copper was forming a complex with our benzimidazole products, and
therefore lowering the isolated yield. A stronger ligand was perhaps needed to remove
the copper and free the final product. Immediately following the coupling reaction, we
added Na2S·9H2O to the reaction and stirred at room temperature for an hour. This
removed all copper coloration from the organic extract, and simultaneously increased
the yields of the coupled product.
Next, an array of substrates was screened with the optimized conditions to
determine the scope of the reaction (Table 2). Comparing compounds 2, 5, 16, and 17
gave evidence that the presence of an electron donating group on the benzimidazole
moiety increased the coupling yield; however, electron withdrawing functionalities on
the benzimidazole, compound 9, seemed to hinder coupling. When comparing electron
rich and electron poor arene coupling partners, there didn’t appear to be a significant
trend in reactivity. The starting materials for products 8, 9, and 13 were synthesized in
inseparable mixtures, thus the cyclization reactions produced mixtures of isomers.
The cyclization was successful in forming a new six-membered ring, compound 21,
but failed to couple compounds 19 and 20, which would have produced new seven
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membered rings. This indicated that the length of the tether highly influenced the
success of the reaction.

Table 2- Scope of the Cyclization of N-benzylbenzimidazolesa
a

Reaction conditions: 0.384 mmol substrate, 20 mol% Pd(OAc)2, Cu(OAc)2•H2O (0.768
mmol), CuOAc (0.192 mmol), CsOPiv (0.960 mmol) in 5 mL of 1,4-dioxane at 150 ˚C
for 3 hr under microwave heating. Isolated yields throughout.
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Intramolecular

coupling

reactions

between

benzimidazole

and

other

heterocycles, such as furan, imidazole, and the caffeine derivative, benzyl
theophylline, were also tried under our optimized conditions; however, the attempts
were unsuccessful. (e.g. 12, 14, 22, Table 2).
Kinetic isotope effects of the reaction were evaluated by carrying out
competition studies. The first competition study utilized equimolar amounts of Nbenzylbenzimidazole and deuterated N-benzyl-d7 benzimidazole, and subjected both
substrates to the optimized coupling conditions. Relative amounts of the products were
obtained from GC-MS analysis and a KIE of 1.03 was obtained (Scheme 2). This
indicated that the metalation of the arene coupling partner was not rate limiting, but
more of a facile step in the reaction.18 A second competition study was carried out
with

equimolar

amounts

of

N-benzylbenzimidazole

and

N-benzyl-3-

deuterobenzimidazole, but the KIE results of this test proved to be inconclusive due to
H/D scrambling.

Scheme 2- KIE Study on Aryl-Benzimidazole Cyclization

With the KIE studies in hand, we sought to propose a plausible mechanism for
this unique intramolecular CDC reaction. Based on all data, it seemed that the
coupling was taking place through a PdII/CuI catalyzed system. Our reasoning behind
the dual metal catalysis was supported by several factors. It was known from previous
studies that Cu(I) was capable of enhancing azole coupling,8-11 so we speculated that
Cu(I) was needed to activate the C2 position of the benzimidazole. Because the
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addition of Cu(I) only raised the percent yield slightly (Table 1, entry 10), we needed
to be sure that the addition of Cu(I) was in fact essential in the formation of the
product. Since the Cu(OAc)2 oxidant could diporpotionate into Cu(I), we theorized
that there was perhaps some Cu(I) present to catalyze the reaction. This would explain
why we did not see a significant raise in yield upon the addition of a Cu(I) source.
To test whether Cu(I) was utilized in the mechanism, we had to eliminate the
use of Cu(OAc)2 as an oxidant. (Scheme 3) A control was carried out using AgOAc as
an oxidant and Pd(OAc)2 as the only catalyst. The GC-MS results showed that there
was low conversion of the starting material into a small amount of the acetoxylated
product 2 and dimer 4. None of the desired arylation product 2 was formed, suggesting
that Cu is needed in the reaction.

Scheme 3- Control Reactions Using AgOAc as an Oxidant

We next ran a second control using only a Cu(I) catalyst and AgOAc as the
oxidant. The GC-MS results showed there was a low conversion of the starting
material into the dimer 4. (Scheme 3) Consequently, we concluded that Cu(I) could
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activate the benzimidazole moiety and form the benzimidazole dimer. This control
also supported that Pd played a pivatol role in the activation of the arene for coupling.
Our proposed mechanism (Scheme 4) utilizes two independent metalation
steps. First, Cu(I) inserts in the 2 position of benzimidazole, forming acetic acid and a
Cu(I)-benzimidazole complex. Next, the arene is palladated, again producing acetic
acid as a byproduct. At this point, a transmetalation could occur in which CuOAc is
released and a biaryl Pd(II) complex is formed. The final step of the reaction would
include a simple reductive elimination to form the coupled aryl-benzimidazole product
and Pd(0). Subsequent oxidation of the Pd by the Cu(OAc)2 oxidant would regenerate
both the Pd(II) and Cu(I) catalysts. To our knowledge, two independent C-H
activations by different metals followed by a single transmetallation, is a novel
mechanism, and would warrant future investigations.

Scheme 4-Proposed Mechanism for the Pd(II)/Cu(I) Catalyzed Cyclization of Nbenzylbenzimidazoles

Based on the KIE studies, it was concluded that the palladation of the arene is
not rate limiting and does not go through a concerted metalation deprotonation (CMD)
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mechanism. Instead it more likely proceeds through some kind of electrophilic
aromatic metalation. For a CMD mechanism a much higher KIE value of 3-4 would
have been expected, since the rate limiting step consists of simultaneous C-H bond
cleavage and palladation. Electrophilic metalation on the other hand, would have a
lower KIE value, since palladation occurs before deprotonation. Electrophilic
palladation of the arene causes a loss of aromaticity, which provides for easy
subsequent deprotonation of arene in order to restore aromaticity.

Conclusions
In conclusion, we have developed an intramolecular coupling reaction between
the 2-position of benzimidazole and a tethered arene to form fused polycyclic
heterocycles. The use of cross-dehydrogenative coupling in this reaction makes it
highly atom economical and cost efficient, since no prefunctionalization is required.
Mechanistic investigations led us to propose that the reaction proceeds via a dual
PdII/CuI catalyst system with a Cu(OAc)2 oxidant. A large library of electron poor and
electron rich arene-benzimidazoles were coupled in moderate yields, suggesting that
this reaction could be a valuable tool in the synthesis of biologically useful
heterocyclic compounds.

Methods
Representative Procedure for CDC Coupling. A magnetically stirred solution of Nbenzylbenzimidazole (82 mg, 0.395 mmol), palladium acetate (18 mg, 0.076 mmol),
copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg,
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0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude
product was then purified via column chromatography to give pure 2 (82 mg, 53%
yield). The product was analyzed by GC-MS, and

1

H NMR and

13

C NMR

spectroscopy.
Representative Procedure for Synthesizing N-Tethered Starting Materials. Under
an inert nitrogen atmosphere, benzimidazole (4.0 g, 33.8 mmol) was added to a
solution of potassium tert-butoxide (5.7 g, 50.8 mmol) in 40 mL of DMF at 0 ˚C and
magnetically stirred for 15 minutes. To the mixture was added a solution of benzyl
chloride (4.7 g, 37.3 mmol) in an additional 15 mL of DMF. The mixture was then left
to warm to room temperature and stirred for 2 hours. After the reaction was complete,
it was quenched with 90 mL of water and extracted three times with 90 mL portions of
ethyl acetate. The organic extracts were washed with three 90 mL portions of water
followed by three 90 mL portions of brine. The organic extracts were dried with
magnesium sulfate and condensed at reduced pressure. The crude product was then
purified via column chromatography to give pure N-benzylbenzimidazole (4.10 g,
58% yield). The product was analyzed by GC-MS, and 1H NMR and
spectroscopy.
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Experimental Section
The novel compounds synthesized are reported below.
Reagents
All reagents, including benzimidazoles, benzyl chlorides, sodium sulfide
nonahydrate, potassium tert-butoxide, ethyl acetate, hexanes, 1-4-dioxane, copper(II)
acetate monohydrate, copper(I) acetate, and cesium pivalate were purchased from
Fisher Scientific and Sigma Aldrich and used without purification. Column
chromatography was performed on Silicycle silica gel (60 Å, 40-63 µm). Palladium
(II)

acetate

was

purchased

from

Precious

Metals

Online

(http://www.precmet.com/au/). It was then dried at 100 ˚C for approximately 6 hours
under vacuum. All reagents were stored in an inert nitrogen atmosphere.

Instrumentation
Reactions were carried out with a CEM Discover Microwave. A Bruker
Avance 300 MHz spectrometer and a JEOL GSX 400 MHz spectrometer were used
for NMR analysis. GC/MS analysis was carried out with an Agilent Technologies
6890 GC fixed with a 5973 Mass Selective Detector.
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Synthesis of 11-H-Isoindolo[2,1-a]benzimidazole (2)

A magnetically stirred solution of N-benzylbenzimidazole (80 mg, 0.384 mmol),
palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115 mg,
0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg, 0.768
mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the
reaction mixture and stirred at room temperature for 1 hour. The mixture was then
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was
condensed at reduced pressure. The crude product was then purified via column
chromatography to give pure 2 (45 mg, 58% yield). The product was analyzed by GCMS, and 1H NMR and 13C NMR spectroscopy.
Rf-Value: Hexanes/Ethyl acetate (70:30 v/v) = 0.4
1

H NMR (300 MHz, CDCl3) δ= 8.02 (dd, J= 6.5 Hz, 1.39 Hz, 1H), 7.83-7.81 (m,
1H), 7.53-7.44 (m, 3H), 7.39-7.36 (m, 1H), 7.26-7.23 (m, 2H), 4.95 (s, 2H)
13

C NMR (75 MHz, CDCl3) δ= 158.46, 148.34, 143.48, 132.63, 129.47, 129.32,
128.70, 123.83, 122.64, 122.14, 121.98, 120.48, 109.32, 47.17
LRMS EI (m/z): [M+] calc’d for C14H10N2 206.1, observed 206.2
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Spectrum 1- 1H NMR of Compound 2
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Spectrum 2- 13C NMR of Compound 2
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Synthesis of 3

A magnetically stirred solution of N-benzylbenzimidazole (125 mg, 0.6 mmol),
palladium acetate (14 mg, 0.06 mmol), copper(II) acetate (479 mg, 2.4 mmol), and 4.5
mL dioxane was microwave heated 160 ˚C for 1 hours. The mixture was then filtered,
using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was condensed at
reduced pressure. The crude product was then purified via column chromatography to
give pure 3 (33 mg, 21% yield). The product was analyzed by GC-MS, and 1H NMR
and 13C NMR spectroscopy.

Rf-Value: Hexanes/Ethyl acetate (70:30 v/v) = 0.30
1

H NMR (300 MHz, CDCl3) δ= 7.97 (d, J= 7.4 Hz , 1H), 7.82-7.79 (m, 1H), 7.607.57 (m, 2H), 7.55 (s, 1H), 7.52-7.47 (m, 2H), 7.30-7.27 (m, 2H), 2.24 (s, 3H)
13

C NMR (75 MHz, CDCl3) δ=170.98, 157.28, 148.60, 143.47, 131.89, 130.92,
130.41, 129.44, 126.73, 125.03, 123.98, 122.94, 122.16, 120.76, 110.78, 20.93
LRMS EI (m/z): [M+] calc’d for C16H12N2O2 264.1, observed 264.1
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Spectrum 3- 1H NMR of Compound 3
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Spectrum 4- 13C NMR of Compound 3
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Synthesis of 7

A magnetically stirred solution of N-(3-chlorobenzyl)-benzimidazole (0.093 mg, 0.384
mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115
mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg,
0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the
reaction mixture and stirred at room temperature for 1 hour. The mixture was then
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was
condensed at reduced pressure. The crude product was then purified via column
chromatography to give pure 7 (13 mg, 15% yield). The product was analyzed by GCMS, and 1H NMR and 13C NMR spectroscopy.

1

H NMR (300 MHz, CDCl3) δ = 7.97 (d, J= 8.2 Hz, 1H) , 7.83 (dd, J= 6.0 Hz, 3.2 Hz,
1H) , 7.56 (sd, J= 1.8 Hz, 1H) , 7.51 (dd, J= 8.2 Hz, 1.8 Hz, 1H) , 7.44 (dd, J= 6.0, 3.2
Hz, 1H) , 7.30 (d, J=3.2 Hz, 1H) 7.29 (d, J=3.2 Hz, 1H), 5.04 (s, 2H)
13

C NMR (75 MHz, CDCl3) δ= 145.92, 139.03, 136.52, 130.22, 128.93, 125.31,
123.91, 123.87, 123.75, 123.37, 123.03, 121.61, 110.30, 47.95
LRMS EI (m/z): [M+] calc’d for C14H9ClN2 240.0, observed 240.0
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Spectrum 5- 1H NMR of Compound 7
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Spectrum 6- 13C NMR of Compound 7
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Synthesis of 9

A magnetically stirred solution of a mixture of N-benzyl- (5-nitro and 6nitro)benzimidazole (97 mg, 0.384 mmol), palladium acetate (18 mg, 0.076 mmol),
copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg,
0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude
product was then purified via column chromatography to give pure 9 (26 mg, 29%
yield). The product was analyzed by GC-MS, and

1

H NMR and

13

C NMR

spectroscopy.

1

H NMR (300 MHz, CDCl3) δ= 8.69 (d, J= 1.7 Hz, 1H, isomer A), 8.40 (d, J= 1.7 Hz,
1H, isomer B), 8.24-8.20 (m, 1H, isomer A and B) 8.09 (s, J= 3.84 Hz, 1H, isomer A
and B) 7.85 (d, J= 9.0 Hz, 1H, isomer B), 7.64-7.56 (m, 3H, isomer A and B), 7.49 (d,
J= 8.6 Hz, 1H, isomer A), 5.17 (s, 2H, isomer B), 5.13 (s, 2H, isomer A)
13

C NMR (75 MHz, CDCl3) (isomer A) δ= 143.50, 138.73, 133.12, 130.83, 129.24,
124.16, 122.83, 120.21, 119.39, 118.77, 116.95, 109.04, 106.16, 47.63
LRMS EI (m/z): [M+] calc’d for C14H9N3O2 251.1, observed 251.1
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Spectrum 7- 1H NMR of Compound 9
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Spectrum 8- 13C NMR of Compound 9
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Synthesis of 11

A

magnetically

stirred

solution

of

N-(3-(trifluoromethyl)benzyl)-5,6-

dimethylbenzimidazole (117 mg, 0.384 mmol), palladium acetate (18 mg, 0.076
mmol), copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24
mg, 0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude
product was then purified via column chromatography to give pure 11 (57 mg, 50%
yield). The product was analyzed by GC-MS, and

1

H NMR and

13

C NMR

spectroscopy.

1

H NMR (300 MHz, CDCl3) δ = 8.08 (d, J= 8.0 Hz, 1H) , 7.79 (s, 1H), 7.75 (d, J=
8.0 Hz, 1H), 7.57 (s, 1H), 7.23 (s, 1H), 5.02 (s, 2H), 2.39 (s, 3H), 2.38 (s, 3H)
13

C NMR (75 MHz, CDCl3), 19F not decoupled δ= 143.67, 132.95, 132.86, 126.14,
126.09, 125.72, 121.96, 121.00, 120.93, 120.88, 120.82, 120.79, 109.91, 47.22, 29.71,
20.57, 20.40
LRMS EI (m/z): [M+] calc’d for C17H13F3N2 302.1, observed 302.1
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Spectrum 9- 1H NMR of Compound 11
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Spectrum 10- 13C NMR of Compound 11
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Synthesis of 15

A magnetically stirred solution of N-(2-methoxybenzyl)-benzimidazole (80 mg, 0.33
mmol), palladium acetate (15 mg, 0.067 mmol), copper(II) acetate monohydrate (101
mg, 0.504 mmol), copper(I) acetate (21 mg, 0.17 mmol), cesium pivalate (157 mg,
0.672 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the
reaction mixture and stirred at room temperature for 1 hour. The mixture was then
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was
condensed at reduced pressure. The crude product was then purified via column
chromatography to give pure 15 (34 mg, 43% yield). The product was analyzed by
GC-MS, and 1H NMR and 13C NMR spectroscopy.

Rf-Value: Hexane/Ethyl acetate (50:50 v/v) = 0.30
1

H NMR (300 MHz, CDCl3) δ= 7.83-7.80 (m, 1H), 7.63 (d, J= 7.6 Hz, 1H), 7.47-7.40
(m, 2H), 7.27-7.24 (m, 2H), 6.92 (d, J=8.2 Hz, 1H), 4.90 (s, 2H), 3.90 (s, 3H)
13

C NMR (75 MHz, CDCl3) δ= 158.64, 155.05, 148.33, 132.70, 130.98, 130.68,
130.46, 122.62, 122.04, 120.51, 114.35, 111.29, 109.33, 55.43, 45.39
LRMS EI (m/z): [M+] calc’d for C15H12N2O 236.1, observed 236.1
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Spectrum 11- 1H NMR of Compound 15
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Spectrum 12- 13C NMR of Compound 15
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Synthesis of 16

A magnetically stirred solution of N-(4-methoxybenzyl)-(5,6-dimethyl)benzimidazole
(102 mg, 0.384 mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate
monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium
pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3
hours. After the reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol)
was added to the reaction mixture and stirred at room temperature for 1 hour. The
mixture was then filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the
filtrate was condensed at reduced pressure. The crude product was then purified via
column chromatography to give pure 16 (64 mg, 63% yield). The product was
analyzed by GC-MS, and 1H NMR and 13C NMR spectroscopy.

1

H NMR (300 MHz, CDCl3) δ = 7.49 (s, 1H), 7.44 (sd, J=2.3 Hz, 1H), 7.28 (d, J= 8.3
Hz, 1H), 6.98 (s, 1H), 6.89 (dd, J=8.3 Hz, 2.3 Hz, 1H), 4.61 (s, 2H), 3.83 (s, 3H), 2.32
(s, 3H), 2.26 (s, 3H)
13

C NMR (75 MHz, CDCl3) δ= 20.03, 20.40, 46.50, 55.53, 105.41, 109.54, 116.26,
120.27, 124.34, 130.62, 130.74, 131.08, 131.70, 135.34, 146.61, 157.50, 160.04
LRMS EI (m/z): [M+] calc’d for C17H16N2O 264.1, observed 264.1
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Spectrum 13- 1H NMR of Compound 16
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Spectrum 14- 13C NMR of Compound 16
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Synthesis of 17

A magnetically stirred solution of N-(4-methoxybenzyl)-benzimidazole (91 mg, 0.384
mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115
mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg,
0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the
reaction mixture and stirred at room temperature for 1 hour. The mixture was then
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was
condensed at reduced pressure. The crude product was then purified via column
chromatography to give pure 17 (49 mg, 54% yield). The product was analyzed by
GC-MS, and 1H NMR and 13C NMR spectroscopy.

1

H NMR (400 MHz, CDCl3) δ= 7.80 (d, J= 7.0 Hz, 1H), 7.52 (s, 1H), 7.38-7.34 (m,
2H), 7.25-7.22 (m, 2H), 6.98 (d, J= 8.4 Hz, 1H), 4.85 (s, 2H), 3.86 (s, 3H)
13

C NMR (101 MHz, CDCl3) δ= 160.23, 148.19, 138.10, 135.37, 132.72, 130.46,
124.52, 122.62, 122.08, 120.43, 116.89, 109.31, 105.76, 55.61, 46.78
LRMS EI (m/z): [M+] calc’d for C15H12N2O 236.1, observed 236.1
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Spectrum 15- 1H NMR of Compound 17
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Spectrum 16- 13C NMR of Compound 17
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Synthesis of N-benzylbenzimidazole

Under an inert nitrogen atmosphere, benzimidazole (4.0 g, 33.8 mmol) was added to a
solution of potassium tert-butoxide (5.7 g, 50.8 mmol) in 40 mL of DMF at 0 ˚C and
magnetically stirred for 15 minutes. To the mixture was added a solution of benzyl
chloride (4.7 g, 37.3 mmol) in an additional 15 mL of DMF. The mixture was then left
to warm to room temperature and stirred for 2 hours. After the reaction was complete,
it was quenched with 90 mL of water and extracted three times with 90 mL portions of
ethyl acetate. The organic extracts were washed with three 90 mL portions of water
followed by three 90 mL portions of brine. The organic extracts were dried with
magnesium sulfate and condensed at reduced pressure. The crude product was then
purified via column chromatography to give pure N-benzylbenzimidazole (4.10 g,
58% yield). The product was analyzed by GC-MS, and 1H NMR and

13

C NMR

spectroscopy.

Rf-Value: Hexanes/Ethyl acetate (30:70 v/v) = 0.40
1

H NMR (300 MHz, CDCl3) δ= 7.94 (s, 1H), 7.83 (dd, J= 8.1 Hz, 1.9 Hz, 1H), 7.337.25 (m, 6H) 7.18-7.15 (m, 2H), 5.33 (s, 2H)
13

C NMR (75 MHz, CDCl3) δ= 143.96, 143.21, 135.45, 133.88, 129.00, 128.23,
127.04, 123.04, 122.23, 120.41, 110.01, 48.77
LRMS EI (m/z): [M+] calc’d for C14H12N2 208.1, observed 208.1
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Spectrum 17- 1H NMR of N-benzylbenzimidazole
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Spectrum 18- 13C NMR of N-benzylbenzimidazole
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Synthesis of 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzo[d]imidazole

Under an inert nitrogen atmosphere, tosyl chloride (2.33 g, 12.1 mmol) was added to a
solution of furfuryl alcohol (1.08 g, 11.0 mmol) and triethylamine (2.0mL, 14 mmol)
in 10 mL of methylene chloride at 0 ˚C. The reaction was magnetically stirred and
allowed to warm to room temperature. It was monitored by TLC until the reaction was
complete. A second reaction mixture of 5,6-dimethylbenzimidazole (3.38 g, 23.1
mmol) and potassium tert-butoxide (3.87 g, 34.4 mmol) in 30 mL of methylene
chloride was magnetically stirred for 30 minutes at room temperature. It was then
cooled to 0 ˚C, and the first reaction mixture was added directly. The whole mixture
was then left to warm to room temperature and stirred for 4-6 hours. After the reaction
was complete, it was quenched with 50 mL of water and extracted three times with 10
mL portions of methylene chloride. The organic extracts were washed with two 30 mL
portions of brine followed by two 10 mL portions of saturated sodium bicarbonate
solution. The organic extracts were dried with magnesium sulfate and condensed at
reduced pressure. The crude product was then purified via column chromatography to
give pure 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzo[d]imidazole (0.52g , 21%
yield). The product was analyzed by GC-MS, and

1

H NMR and

13

C NMR

spectroscopy.
Rf-Value: Hexane/Ethyl acetate (30:70 v/v) = 0.33
1

H NMR (300 MHz, CDCl3) δ= 7.82 (s, 1H), 7.55 (s, 1H), 7.37 (s, 1H), 7.19 (s, 1H),
6.34-6.30 (m, 2H), 5.24 (s, 2H), 2.38 (s, 3H), 2.36 (s, 3H)
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13

C NMR (75 MHz, CDCl3) δ= 148.80, 143.04, 142.39, 142.08, 132.27, 132.22,
131.16, 120.35, 110.59, 109.84, 108.84, 41.67, 20.63, 20.25
LRMS EI (m/z): [M+] calc’d for C14H14N2O 226.1, observed 226.1

79

Spectrum 19- 1H NMR of 1-((furan-3-yl)methyl)-5,6-dimethyl-1H-benzimidazole
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Spectrum 20- 13C NMR of 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzimidazole

81

Synthesis of 1-(3-(trifluoromethyl)benzyl)-5,6-dimethyl-1H-benzo[d]imidazole

Under an inert nitrogen atmosphere, 5,6-dimethylbenzimidazole (1.0 g, 6.8 mmol) was
added to a solution of potassium hydroxide (0.58 g, 10.3 mmol) in 20 mL of DMF and
magnetically stirred for 30 minutes at room temperature. The mixture was cooled to 0
˚C and 3-trifluoromethyl benzyl chloride (1.16 mL, 7.52 mmol) was added. The
mixture was then left to warm to room temperature and monitored by TLC. After the
reaction was complete, it was quenched with 30 mL of water and extracted three times
with 20 mL portions of ethyl acetate. The organic extracts were washed with 20 mL of
DI water followed by two 20 mL portions of brine. The organic extracts were dried
with magnesium sulfate and condensed at reduced pressure. The crude product was
then purified via column chromatography to give pure 1-(3-(trifluoromethyl)benzyl)5,6-dimethyl-1H-benzo[d]imidazole (1.52 g, 73% yield). The product was analyzed
by GC-MS, and 1H NMR and 13C NMR spectroscopy.

Rf-Value: Hexane/Ethyl acetate (10:90 v/v) = 0.33
1

H NMR (300 MHz, CDCl3) δ= 7.84 (s, 1H), 7.60 (s, 1H), 7.56 (d, J= 7.7 Hz), 7.49
(s, 1H), 7.42 (t, J= 7.7, 1H), 7.24 (d, J=7.7 Hz, 1H), 7.00 (s, 1H), 5.34 (s, 2H), 2.36 (s,
3H), 2.32 (s, 3H)
13

C NMR (75 MHz, CDCl3), 19F not decoupled δ= 142.60, 142.35, 136.97, 132.64,
132.26, 131.49, 130.07, 129.66, 126.98, 125.60, 125.07 (q, JC-F= 3.9 Hz), 123.67 (q,
JC-F= 3.9 Hz), 121.99, 120.55, 109.86, 48.13, 20.59
LRMS EI (m/z): [M+] calc’d for C17H15F3N2 304.1, observed 304.1
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  Spectrum 21- 1H NMR of 1-(3-(trifluoromethyl)benzyl)-5,6-dimethyl-1H-benzimidazole	
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  Spectrum 22- 13C NMR of 1-(3-(trifluoromethyl)benzyl)-5,6-dimethyl-1H-benzimidazole	
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